 <h1>Citalopram Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><h2>In Summary</h2><p><b>Commonly reported side effects of citalopram include:</b> drowsiness, ejaculatory disorder, nausea, insomnia, and diaphoresis. <b>Other side effects include:</b> suicidal tendencies, agitation, diarrhea, impotence, sinusitis, anxiety, confusion, exacerbation of depression, lack of concentration, tremor, vomiting, anorexia, and xerostomia.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to citalopram: oral solution, oral tablet</i></p><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Tablet; Solution)</p><p>Antidepressants increased the risk of suicidal thinking and behavior in children, adolescents, and young adults in short-term studies with major depressive disorder (MDD) and other psychiatric disorders. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared with placebo in adults beyond age 24, and there was a reduction in risk with antidepressants compared with placebo in adults aged 65 or older. This risk must be balanced with the clinical need. Monitor patients closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. Not approved for use in pediatric patients.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, citalopram may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking citalopram:</p><p>
<i>Less common</i>
</p><ul>
<li>Agitation</li>
<li>blurred vision</li>
<li>confusion</li>
<li>fever</li>
<li>increase in the frequency of urination or amount of urine produced</li>
<li>lack of emotion</li>
<li>loss of memory</li>
<li>menstrual changes</li>
<li>skin rash or itching</li>
<li>trouble breathing</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Behavior change similar to drunkenness</li>
<li>bleeding gums</li>
<li>breast tenderness or enlargement or unusual secretion of milk (in females)</li>
<li>chills</li>
<li>convulsions (seizures)</li>
<li>diarrhea</li>
<li>difficulty with concentrating</li>
<li>dizziness or fainting</li>
<li>drowsiness</li>
<li>increased hunger</li>
<li>increased thirst</li>
<li>irregular heartbeat</li>
<li>lack of energy</li>
<li>lethargy</li>
<li>nosebleed</li>
<li>overactive reflexes</li>
<li>painful urination</li>
<li>poor coordination</li>
<li>purple or red spots on the skin</li>
<li>rapid weight gain</li>
<li>red or irritated eyes</li>
<li>redness, tenderness, itching, burning, or peeling of the skin</li>
<li>shivering</li>
<li>slow or irregular heartbeat (less than 50 beats per minute)</li>
<li>sore throat</li>
<li>stupor</li>
<li>sweating</li>
<li>swelling of the face, ankles, or hands</li>
<li>talking or acting with excitement you cannot control</li>
<li>trembling, shaking, or twitching</li>
<li>trouble with holding or releasing urine</li>
<li>unusual or sudden body or facial movements or postures</li>
<li>unusual tiredness or weakness </li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Abdominal or stomach pain</li>
<li>back or leg pains</li>
<li>black, tarry stools</li>
<li>bloating</li>
<li>bloody stools</li>
<li>chest pain</li>
<li>confusion as to time, place, or person</li>
<li>constipation</li>
<li>cough</li>
<li>darkened urine</li>
<li>difficult or fast breathing</li>
<li>difficulty with swallowing</li>
<li>drooling</li>
<li>fast, slow, or irregular heartbeat</li>
<li>general body swelling</li>
<li>hive-like swelling on the face, eyelids, lips, tongue, or throat</li>
<li>hives</li>
<li>holding false beliefs that cannot be changed by fact</li>
<li>impaired consciousness, ranging from confusion to coma</li>
<li>indigestion</li>
<li>itching, puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>loss of appetite</li>
<li>loss of bladder control</li>
<li>loss of consciousness</li>
<li>muscle cramps or spasms</li>
<li>muscle tightness</li>
<li>muscle twitching or jerking</li>
<li>painful or prolonged erection of the penis</li>
<li>pale skin</li>
<li>penile erections, frequent or continuing</li>
<li>recurrent fainting</li>
<li>rhythmic movement of the muscles</li>
<li>seeing, hearing, or feeling things that are not there</li>
<li>swelling of the breasts or unusual milk production</li>
<li>tenderness, pain, swelling, warmth, skin discoloration, and prominent superficial veins over the affected area</li>
<li>tightness in the chest</li>
<li>total body jerking</li>
<li>twitching, twisting, uncontrolled repetitive movements of the tongue, lips, face, arms, or legs</li>
<li>uncontrolled jerking or twisting movements</li>
<li>unusual excitement</li>
<li>vomiting of blood or material that looks like coffee grounds</li>
<li>yellowing of the eyes or skin</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of citalopram may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Decrease in sexual desire or ability</li>
<li>sleepiness or unusual drowsiness</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Body aches or pain</li>
<li>change in sense of taste</li>
<li>gas</li>
<li>headache (severe and throbbing)</li>
<li>heartburn</li>
<li>increased sweating</li>
<li>increased yawning</li>
<li>loss of voice</li>
<li>pain in the muscles or joints</li>
<li>sneezing</li>
<li>stuffy or runny nose</li>
<li>tingling, burning, or prickly feelings on the skin</li>
<li>tooth grinding</li>
<li>unusual increase or decrease in weight</li>
<li>watering of the mouth</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Bruising</li>
<li>inability to sit still</li>
<li>large, flat, blue or purplish patches in the skin</li>
<li>need to keep moving</li>
<li>uncontrolled eye movements</li>
</ul><p>
<!-- end oral solution, oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to citalopram: oral solution, oral tablet</i></p><h3>General</h3><p>The side effects observed with citalopram in clinical trials were generally reported as mild and transient, occurring most frequently in the first 1 to 2 weeks of therapy, and attenuating subsequently.  The most commonly reported side effects were nausea, somnolence, dry mouth, increased sweating, tremor, diarrhea, and ejaculation disorder.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 26.9%), somnolence (up to 17.9%), dizziness (up to 10.3%)</p>
<p><b>Common</b> (1% to 10%): Amnesia, extrapyramidal disorder, migraine, paresthesia, tremor,</p>
<p><b>Uncommon</b> (0.1% to 1%): Abnormal gait, ataxia, cerebrovascular accident, convulsions, dystonia, hypoesthesia, involuntary muscle contractions, neuralgia, speech disorder, syncope, hyperkinesia, hypertonia, hypokinesia, dyskinesia, vertigo, transient ischemic attack</p>
<p><b>Rare</b> (less than 0.1%): Abnormal coordination, dyskinesia, grand mal convulsion, hyperesthesia, stupor</p>
<p><b>Frequency not reported</b>: Akathisia, movement disorder, serotonin syndrome</p>
<p><b>Postmarketing reports</b>: Choreoathetosis, myoclonus, neuroleptic malignant syndrome, nystagmus<sup>[Ref]</sup></p><p>Potentially life-threatening serotonin syndrome has been reported with SSRIs and SNRIs as monotherapy, but particularly with concomitant use of other serotonergic drugs and drugs that impair the metabolism of serotonin.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (up to 21.4%), dry mouth (up to 20%)</p>
<p><b>Common</b> (1% to 10%): Abdominal pain, constipation, diarrhea, dyspepsia, flatulence, increased saliva, taste loss/perversion, vomiting</p>
<p><b>Uncommon</b> (0.1% to 1%): Abnormal bleeding (predominantly of the mucous membranes), dysphagia, eructation, esophagitis, gastrointestinal bleeding, gastritis, gastroenteritis, gingivitis, hemorrhoids, stomatitis, teeth grinding</p>
<p><b>Rare</b> (less than 0.1%): Colitis, diverticulitis, duodenal ulcer, gastric ulcer, gastroesophageal reflux, gingival bleeding, glossitis, rectal hemorrhage</p>
<p><b>Frequency not reported</b>: Gastrointestinal hemorrhage</p>
<p><b>Postmarketing reports</b>: Pancreatitis<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Insomnia (up to 18.8%)</p>
<p><b>Common</b> (1% to 10%): Abnormal dreams, aggravated depression, agitation, anxiety, apathy, confusion, depression, impaired concentration, nervousness, suicide attempt, sleep disorder</p>
<p><b>Uncommon</b> (0.1% to 1%): Aggressive reaction, delusion, depersonalization, drug dependence, emotional lability, euphoria, hallucination, mania, panic reaction, paranoid reaction, paroniria, psychosis, psychotic depression</p>
<p><b>Rare</b> (less than 0.1%): Catatonic reaction, melancholia, suicide-related events</p>
<p><b>Frequency not reported</b>: Bruxism, restlessness, panic attack, suicidal ideation/behavior</p>
<p><b>Postmarketing reports</b>: Delirium, withdrawal syndrome<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Asthenia (up to 11.5%)</p>
<p><b>Common</b> (1% to 10%): Fatigue, fever/pyrexia, tinnitus, asthenia</p>
<p><b>Rare</b> (less than 0.1%): Facial edema, malaise, rigors</p>
<p><b>Postmarketing reports</b>: Spontaneous abortion<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Increased sweating (up to 11.3%)</p>
<p><b>Common</b> (1% to 10%): Rash, pruritus</p>
<p><b>Uncommon</b> (0.1% to 1%): Abnormal bleeding of the skin, acne, alopecia, dermatitis, dry skin, eczema, flushing, photosensitivity reaction, psoriasis, purpura, skin discoloration, urticaria</p>
<p><b>Rare</b> (less than 0.1%): Decreased sweating, cellulitis, hypertrichosis, keratitis, melanosis, pruritus ani</p>
<p><b>Frequency not reported</b>: Angioedema, ecchymosis</p>
<p><b>Postmarketing reports</b>: Epidermal necrolysis, erythema multiforme<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Abnormal orgasm/anorgasmia (female), amenorrhea, decreased libido, dysmenorrhea, ejaculation disorders/ejaculation delay, impotence, menstrual disorders, polyuria, ejaculation failure, micturition disorders</p>
<p><b>Uncommon</b> (0.1% to 1%): Breast enlargement, breast pain, dysuria, galactorrhea, increased libido, menorrhagia, micturition frequency, nonpuerperal lactation, vaginal bleeding, vaginal hemorrhage, urinary incontinence, urinary retention</p>
<p><b>Rare</b> (less than 0.1%): Hematuria, oliguria</p>
<p><b>Frequency not reported</b>: Metrorrhagia, priapism<sup>[Ref]</sup></p><p>Urinary retention and galactorrhea have been reported with other SSRIs.  </p>
<p></p>
<p>The estimates of the incidence of untoward sexual experience and performance may underestimate their actual incidence, partly because patients and physicians may be reluctant to discuss this issue.  In placebo-controlled clinical trials, ejaculation disorder (primarily ejaculation delay) was reported as a treatment-emergent side effect at an incidence of 6% and at least twice the incidence in placebo-treated male patients.<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Coughing, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, yawning</p>
<p><b>Uncommon</b> (0.1% to 1%): Bronchitis, dyspnea, epistaxis, pneumonia</p>
<p><b>Rare</b> (less than 0.1%): Asthma, bronchospasm, hiccups, increased sputum, laryngitis, pneumonitis, pulmonary embolism<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Chest pain, hypotension, palpitations, postural hypotension, tachycardia</p>
<p><b>Uncommon</b> (0.1% to 1%): Angina pectoris, atrial fibrillation, bradycardia, cardiac failure, edema (extremities), extrasystoles, hematomas, hot flushes, hypertension, myocardial infarction, myocardial ischemia</p>
<p><b>Rare</b> (less than 0.1%): Bundle branch block, cardiac arrest, phlebitis, QT prolongation, torsades de pointes</p>
<p><b>Frequency not reported</b>: Ventricular arrhythmia, orthostatic hypotension</p>
<p><b>Postmarketing reports</b>: Thrombosis<sup>[Ref]</sup></p><p>This drug has been associated with a dose-related QT-interval prolongation; there have been reports of QT-interval prolongation and ventricular arrhythmia, including torsade de pointes, particularly in females, patients with hypokalemia, or with pre-existing QT-interval prolongation, or other cardiac disease.<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>Epidemiological studies, primarily in patients aged 50 years or older, have shown an increased risk of bone fractures in patients receiving SSRIs or TCAs.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Arthralgia, back pain, myalgia</p>
<p><b>Uncommon</b> (0.1% to 1%): Arthritis, leg cramps, muscle weakness, skeletal pain</p>
<p><b>Rare</b> (less than 0.1%): Bursitis, osteoporosis</p>
<p><b>Postmarketing reports</b>: Rhabdomyolysis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Anorexia, decreased/increased weight, decreased/increased appetite</p>
<p><b>Uncommon</b> (0.1% to 1%): Abnormal glucose tolerance, thirst</p>
<p><b>Rare</b> (less than 0.1%): Alcohol intolerance, dehydration, hypokalemia, hyponatremia, hypoglycemia, obesity<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Abnormal accommodation</p>
<p><b>Uncommon</b> (0.1% to 1%): Abnormal vision, conjunctivitis, dry eyes, eye pain, mydriasis</p>
<p><b>Rare</b> (less than 0.1%): Abnormal lacrimation, cataract, diplopia, photophobia, ptosis</p>
<p><b>Frequency not reported</b>: Visual disturbance, acute narrow angle glaucoma</p>
<p><b>Postmarketing reports</b>: Angle-closure glaucoma<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Increased alkaline phosphatase</p>
<p><b>Uncommon</b> (0.1% to 1%): Increased ALT, GGT, and AST</p>
<p><b>Rare</b> (less than 0.1%): Bilirubinemia, cholelithiasis, cholecystitis, hepatitis, jaundice</p>
<p><b>Frequency not reported</b>: Abnormal liver function test</p>
<p><b>Postmarketing reports</b>: Cholestatic hepatitis, hepatic necrosis<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Influenza-like symptoms</p>
<p><b>Rare</b> (less than 0.1%): Hay fever<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Uncommon</b> (0.1% to 1%): Anemia, leukopenia, leukocytosis, lymphadenopathy</p>
<p><b>Rare</b> (less than 0.1%): Coagulation disorder, granulocytopenia, hemorrhage, hypochromic anemia, lymphocytosis, lymphopenia</p>
<p><b>Frequency not reported</b>: Thrombocytopenia</p>
<p><b>Postmarketing reports</b>: Decreased prothrombin, hemolytic anemia<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Rare</b> (less than 0.1%): Goiter, hypothyroidism</p>
<p><b>Frequency not reported</b>: Inappropriate ADH secretion</p>
<p><b>Postmarketing reports</b>: Prolactinemia<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Rare</b> (less than 0.1%): Pyelonephritis, renal calculus, renal pain</p>
<p><b>Postmarketing reports</b>: Acute renal failure<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Anaphylactic reaction, hypersensitivity not otherwise specified</p>
<p><b>Postmarketing reports</b>: Allergic reaction<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Celexa (citalopram)." Forest Pharmaceuticals, St. Louis, MO. </p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>SSRI’s vs SNRI’s - What's the difference between them?</li>
<li>What is the difference between Celexa and Lexapro?</li>
<li>What are some common side effects of antidepressants?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about citalopram</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Patient Tips</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Support Group</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>1903 Reviews</li>
<li>Drug class: selective serotonin reuptake inhibitors</li>
<li>FDA Alerts (10)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Citalopram &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Celexa</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +4 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Anxiety and Stress</li>
<li>Bipolar Disorder</li>
<li>Body Dysmorphic Disorder</li>
<li>Agitation</li>
<li data-more-config-id="list-data-resources-conditions">... +17 more</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to citalopram: oral solution, oral tablet</i></p><h3>General</h3><p>The side effects observed with citalopram in clinical trials were generally reported as mild and transient, occurring most frequently in the first 1 to 2 weeks of therapy, and attenuating subsequently.  The most commonly reported side effects were nausea, somnolence, dry mouth, increased sweating, tremor, diarrhea, and ejaculation disorder.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 26.9%), somnolence (up to 17.9%), dizziness (up to 10.3%)</p><p><b>Common</b> (1% to 10%): Amnesia, extrapyramidal disorder, migraine, paresthesia, tremor,</p><p><b>Uncommon</b> (0.1% to 1%): Abnormal gait, ataxia, cerebrovascular accident, convulsions, dystonia, hypoesthesia, involuntary muscle contractions, neuralgia, speech disorder, syncope, hyperkinesia, hypertonia, hypokinesia, dyskinesia, vertigo, transient ischemic attack</p><p><b>Rare</b> (less than 0.1%): Abnormal coordination, dyskinesia, grand mal convulsion, hyperesthesia, stupor</p><p><b>Frequency not reported</b>: Akathisia, movement disorder, serotonin syndrome</p><p><b>Postmarketing reports</b>: Choreoathetosis, myoclonus, neuroleptic malignant syndrome, nystagmus<sup>[Ref]</sup></p><p>Potentially life-threatening serotonin syndrome has been reported with SSRIs and SNRIs as monotherapy, but particularly with concomitant use of other serotonergic drugs and drugs that impair the metabolism of serotonin.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (up to 21.4%), dry mouth (up to 20%)</p><p><b>Common</b> (1% to 10%): Abdominal pain, constipation, diarrhea, dyspepsia, flatulence, increased saliva, taste loss/perversion, vomiting</p><p><b>Uncommon</b> (0.1% to 1%): Abnormal bleeding (predominantly of the mucous membranes), dysphagia, eructation, esophagitis, gastrointestinal bleeding, gastritis, gastroenteritis, gingivitis, hemorrhoids, stomatitis, teeth grinding</p><p><b>Rare</b> (less than 0.1%): Colitis, diverticulitis, duodenal ulcer, gastric ulcer, gastroesophageal reflux, gingival bleeding, glossitis, rectal hemorrhage</p><p><b>Frequency not reported</b>: Gastrointestinal hemorrhage</p><p><b>Postmarketing reports</b>: Pancreatitis<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Insomnia (up to 18.8%)</p><p><b>Common</b> (1% to 10%): Abnormal dreams, aggravated depression, agitation, anxiety, apathy, confusion, depression, impaired concentration, nervousness, suicide attempt, sleep disorder</p><p><b>Uncommon</b> (0.1% to 1%): Aggressive reaction, delusion, depersonalization, drug dependence, emotional lability, euphoria, hallucination, mania, panic reaction, paranoid reaction, paroniria, psychosis, psychotic depression</p><p><b>Rare</b> (less than 0.1%): Catatonic reaction, melancholia, suicide-related events</p><p><b>Frequency not reported</b>: Bruxism, restlessness, panic attack, suicidal ideation/behavior</p><p><b>Postmarketing reports</b>: Delirium, withdrawal syndrome<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Asthenia (up to 11.5%)</p><p><b>Common</b> (1% to 10%): Fatigue, fever/pyrexia, tinnitus, asthenia</p><p><b>Rare</b> (less than 0.1%): Facial edema, malaise, rigors</p><p><b>Postmarketing reports</b>: Spontaneous abortion<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Increased sweating (up to 11.3%)</p><p><b>Common</b> (1% to 10%): Rash, pruritus</p><p><b>Uncommon</b> (0.1% to 1%): Abnormal bleeding of the skin, acne, alopecia, dermatitis, dry skin, eczema, flushing, photosensitivity reaction, psoriasis, purpura, skin discoloration, urticaria</p><p><b>Rare</b> (less than 0.1%): Decreased sweating, cellulitis, hypertrichosis, keratitis, melanosis, pruritus ani</p><p><b>Frequency not reported</b>: Angioedema, ecchymosis</p><p><b>Postmarketing reports</b>: Epidermal necrolysis, erythema multiforme<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Abnormal orgasm/anorgasmia (female), amenorrhea, decreased libido, dysmenorrhea, ejaculation disorders/ejaculation delay, impotence, menstrual disorders, polyuria, ejaculation failure, micturition disorders</p><p><b>Uncommon</b> (0.1% to 1%): Breast enlargement, breast pain, dysuria, galactorrhea, increased libido, menorrhagia, micturition frequency, nonpuerperal lactation, vaginal bleeding, vaginal hemorrhage, urinary incontinence, urinary retention</p><p><b>Rare</b> (less than 0.1%): Hematuria, oliguria</p><p><b>Frequency not reported</b>: Metrorrhagia, priapism<sup>[Ref]</sup></p><p>Urinary retention and galactorrhea have been reported with other SSRIs.  </p><p></p><p>The estimates of the incidence of untoward sexual experience and performance may underestimate their actual incidence, partly because patients and physicians may be reluctant to discuss this issue.  In placebo-controlled clinical trials, ejaculation disorder (primarily ejaculation delay) was reported as a treatment-emergent side effect at an incidence of 6% and at least twice the incidence in placebo-treated male patients.<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Coughing, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, yawning</p><p><b>Uncommon</b> (0.1% to 1%): Bronchitis, dyspnea, epistaxis, pneumonia</p><p><b>Rare</b> (less than 0.1%): Asthma, bronchospasm, hiccups, increased sputum, laryngitis, pneumonitis, pulmonary embolism<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Chest pain, hypotension, palpitations, postural hypotension, tachycardia</p><p><b>Uncommon</b> (0.1% to 1%): Angina pectoris, atrial fibrillation, bradycardia, cardiac failure, edema (extremities), extrasystoles, hematomas, hot flushes, hypertension, myocardial infarction, myocardial ischemia</p><p><b>Rare</b> (less than 0.1%): Bundle branch block, cardiac arrest, phlebitis, QT prolongation, torsades de pointes</p><p><b>Frequency not reported</b>: Ventricular arrhythmia, orthostatic hypotension</p><p><b>Postmarketing reports</b>: Thrombosis<sup>[Ref]</sup></p><p>This drug has been associated with a dose-related QT-interval prolongation; there have been reports of QT-interval prolongation and ventricular arrhythmia, including torsade de pointes, particularly in females, patients with hypokalemia, or with pre-existing QT-interval prolongation, or other cardiac disease.<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>Epidemiological studies, primarily in patients aged 50 years or older, have shown an increased risk of bone fractures in patients receiving SSRIs or TCAs.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Arthralgia, back pain, myalgia</p><p><b>Uncommon</b> (0.1% to 1%): Arthritis, leg cramps, muscle weakness, skeletal pain</p><p><b>Rare</b> (less than 0.1%): Bursitis, osteoporosis</p><p><b>Postmarketing reports</b>: Rhabdomyolysis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Anorexia, decreased/increased weight, decreased/increased appetite</p><p><b>Uncommon</b> (0.1% to 1%): Abnormal glucose tolerance, thirst</p><p><b>Rare</b> (less than 0.1%): Alcohol intolerance, dehydration, hypokalemia, hyponatremia, hypoglycemia, obesity<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Abnormal accommodation</p><p><b>Uncommon</b> (0.1% to 1%): Abnormal vision, conjunctivitis, dry eyes, eye pain, mydriasis</p><p><b>Rare</b> (less than 0.1%): Abnormal lacrimation, cataract, diplopia, photophobia, ptosis</p><p><b>Frequency not reported</b>: Visual disturbance, acute narrow angle glaucoma</p><p><b>Postmarketing reports</b>: Angle-closure glaucoma<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Increased alkaline phosphatase</p><p><b>Uncommon</b> (0.1% to 1%): Increased ALT, GGT, and AST</p><p><b>Rare</b> (less than 0.1%): Bilirubinemia, cholelithiasis, cholecystitis, hepatitis, jaundice</p><p><b>Frequency not reported</b>: Abnormal liver function test</p><p><b>Postmarketing reports</b>: Cholestatic hepatitis, hepatic necrosis<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Influenza-like symptoms</p><p><b>Rare</b> (less than 0.1%): Hay fever<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Uncommon</b> (0.1% to 1%): Anemia, leukopenia, leukocytosis, lymphadenopathy</p><p><b>Rare</b> (less than 0.1%): Coagulation disorder, granulocytopenia, hemorrhage, hypochromic anemia, lymphocytosis, lymphopenia</p><p><b>Frequency not reported</b>: Thrombocytopenia</p><p><b>Postmarketing reports</b>: Decreased prothrombin, hemolytic anemia<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Rare</b> (less than 0.1%): Goiter, hypothyroidism</p><p><b>Frequency not reported</b>: Inappropriate ADH secretion</p><p><b>Postmarketing reports</b>: Prolactinemia<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Rare</b> (less than 0.1%): Pyelonephritis, renal calculus, renal pain</p><p><b>Postmarketing reports</b>: Acute renal failure<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Anaphylactic reaction, hypersensitivity not otherwise specified</p><p><b>Postmarketing reports</b>: Allergic reaction<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Celexa (citalopram)." Forest Pharmaceuticals, St. Louis, MO. </p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>SSRI’s vs SNRI’s - What's the difference between them?</li>
<li>What is the difference between Celexa and Lexapro?</li>
<li>What are some common side effects of antidepressants?</li>
</ul><h2>More about citalopram</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Patient Tips</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Support Group</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>1903 Reviews</li>
<li>Drug class: selective serotonin reuptake inhibitors</li>
<li>FDA Alerts (10)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Citalopram &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +4 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Anxiety and Stress</li>
<li>Bipolar Disorder</li>
<li>Body Dysmorphic Disorder</li>
<li>Agitation</li>
<li data-more-config-id="list-data-resources-conditions">... +17 more</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>